Skip to main content
. 2024 Jan 2;30(5):975–983. doi: 10.1158/1078-0432.CCR-23-1829

Figure 2.

Figure 2. Bintrafusp alfa-related AEs occurring in ≥20% of patients (A) and AESIs (B). aBintrafusp alfa–related AE. birAE related or unrelated to bintrafusp alfa and/or other study drugs. cTGFβ inhibition–mediated skin AE related or unrelated to bintrafusp alfa and/or other study drugs.

Bintrafusp alfa-related AEs occurring in ≥20% of patients (A) and AESIs (B). aBintrafusp alfa–related AE. birAE related or unrelated to bintrafusp alfa and/or other study drugs. cTGFβ inhibition–mediated skin AE related or unrelated to bintrafusp alfa and/or other study drugs.